A counterfeit Augmentin, an antibiotic drug used in treating bacterial infections, is in circulation, according to the National Agency for Food and Drug Administration and Control (NAFDAC), Wikkitimes reports.
The agency in a memo dated October 15, 2022, warned Nigerians to be wary of the counterfeit drug — Augmentin 625mg Tabs which were supplied to medicine vendors in Onitsha, Anambra State.
Further, the agency detailed the drug, saying it carries batch number 562626 with a manufacturing date reading April 2021, an expiry date of April 2024 as well as NAFDAC registration number 04-1928.
The “forged” antibiotic drug does not meet the drug labelling requirements, according to NAFDAC.
“No inscription ‘manufactured by’ written on the label — only the address. Manufacturing and Expiry dates don’t meet the acceptable format. No MAS scratch number for verification,” it stated. “The logo “gsk” is not properly positioned as on the original. The above information makes the drug suspected as counterfeit.”
NAFDAC was established in October 1992 to regulate and control the manufacturing, importation, exportation, distribution, advertisement, sale and use of food, drugs, cosmetics, medical devices, packaged water, chemicals and detergents.
